Bai, Xinyu http://orcid.org/0000-0003-4212-1938
Attrill, Grace H. http://orcid.org/0000-0001-8926-6582
Gide, Tuba N.
Ferguson, Peter M. http://orcid.org/0000-0002-8335-0406
Nahar, Kazi J.
Shang, Ping
Vergara, Ismael A. http://orcid.org/0000-0002-2960-2967
Palendira, Umaimainthan http://orcid.org/0000-0002-1113-3306
da Silva, Ines Pires
Carlino, Matteo S.
Menzies, Alexander M.
Long, Georgina V. http://orcid.org/0000-0001-8894-3545
Scolyer, Richard A. http://orcid.org/0000-0002-8991-0013
Wilmott, James S.
Quek, Camelia http://orcid.org/0000-0002-1244-961X
Funding for this research was provided by:
Cancer Institute NSW (ECF1153)
Philanthropy grants in Australia; CLEARBridge Foundation, Tour De Cure and The Ainsworth Foundation
Article History
Received: 16 April 2023
Accepted: 22 March 2024
First Online: 8 April 2024
Competing interests
: G.V.L. is consultant advisor for Agenus, Amgen, Array Biopharma, AstraZeneca, Bayer, BioNTech, Boehringer Ingelheim, Bristol Myers Squibb, Evaxion, Hexal AG (Sandoz Company), Highlight Therapeutics S.L., IO Biotech, Immunocore, Innovent Biologics USA, Merck Sharpe & Dohme, Novartis, PHMR Ltd, Pierre Fabre, Regeneron, SkylineDx B.V., and Scancell. R.A.S. has received fees for professional services from SkylineDx B.V., IO Biotech ApS, MetaOptima Technology Inc., F. Hoffmann-La Roche Ltd, Evaxion, Provectus Biopharmaceuticals Australia, QBiotics, Novartis, Merck Sharp & Dohme, NeraCare, Amgen, Bristol Myers Squibb, Myriad Genetics, and GlaxoSmithKline. M.S.C. is consultant advisor for Amgen, Bristol Myers Squibb, Eisai, Ideaya, Merck Sharp & Dohme, Nektar, Novartis, Oncosec, Pierre Fabre, QBiotics, Regeneron and Roche, and honoraria for Bristol Myers Squibb, Merck Sharp & Dohme, and Novartis. A.M.M. is on the advisory board for Bristol Myers Squibb, Merck Sharp & Dohme, Novartis, Roche, Pierre Fabre, and QBiotics. I.P.S. is on the advisory board for Merk Sharp & Dohme, and has received fees for professional services from Roche, Bristol Myers Squibb, and Merck Sharp & Dohme. The other authors declare no competing interests.